Liuwei Dihuang Pills improve chemotherapy-induced ovarian injury in mice by promoting the proliferation of female germline stem cells.
10.19540/j.cnki.cjcmm.20241212.706
- Author:
Bo JIANG
1
;
Wen-Yan ZHANG
1
;
Guang-di LIN
1
;
Xiao-Qing MA
1
;
Guo-Xia LAN
1
;
Jia-Wen ZHONG
1
;
Ling QIN
1
;
Jia-Li MAI
1
;
Xiao-Rong LI
2
Author Information
1. College of Traditional Chinese Medicine, Ningxia Medical University Yinchuan 750004, China.
2. General Hospital of Ningxia Medical University Yinchuan 750000, China.
- Publication Type:Journal Article
- Keywords:
ICR mice;
Liuwei Dihuang Pills;
female germline stem cells;
premature ovarian failure
- MeSH:
Animals;
Female;
Drugs, Chinese Herbal/administration & dosage*;
Mice;
Cell Proliferation/drug effects*;
Mice, Inbred ICR;
Ovary/cytology*;
Primary Ovarian Insufficiency/genetics*;
Follicle Stimulating Hormone/metabolism*;
Humans;
Anti-Mullerian Hormone/blood*;
Antineoplastic Agents/adverse effects*;
Luteinizing Hormone/metabolism*;
Cyclophosphamide/adverse effects*
- From:
China Journal of Chinese Materia Medica
2025;50(9):2495-2504
- CountryChina
- Language:Chinese
-
Abstract:
This study primarily investigates the effect of Liuwei Dihuang Pills on the activation and proliferation of female germline stem cells(FGSCs) in the ovaries and cortex of mice with premature ovarian failure(POF), and how it improves ovarian function. ICR mice were randomly divided into the control group, model group, Liuwei Dihuang Pills group, Liuwei Dihuang Pills double-dose group, and estradiol valerate group. A mouse model of POF was established by intraperitoneal injection of cyclophosphamide. After successful modeling, the mice were treated with Liuwei Dihuang Pills or estradiol valerate for 28 days. Vaginal smears were prepared to observe the estrous cycle and body weight. After the last administration, mice were sacrificed and sampled. Serum levels of estradiol(E_2), follicle-stimulating hormone(FSH), luteinizing hormone(LH), and anti-Müllerian hormone(AMH) were measured by enzyme-linked immunosorbent assay(ELISA). Hematoxylin-eosin(HE) staining was used to observe ovarian morphology and to count follicles at all stages to evaluate ovarian function. Immunohistochemistry was used to detect the expression of mouse vasa homolog(MVH), a marker of ovarian FGSCs. Immunofluorescence staining, using co-labeling of MVH and proliferating cell nuclear antigen(PCNA), was used to detect the expression and localization of specific markers of FGSCs. Western blot was employed to assess the protein expression of MVH, octamer-binding transcription factor 4(Oct4), and PCNA in the ovaries. The results showed that compared with the control group, the model group exhibited disordered estrous cycles, decreased ovarian index, increased atretic follicles, and a reduced number of follicles at all stages. FSH and LH levels were significantly elevated, while AMH and E_2 levels were significantly reduced, indicating the success of the model. After treatment with Liuwei Dihuang Pills or estradiol valerate, hormone levels improved, the number of atretic follicles decreased, and the number of follicles at all stages increased. MVH marker protein and PCNA proliferative protein expression in ovarian tissue also increased. These results suggest that Liuwei Dihuang Pills regulate estrous cycles and hormone disorders in POF mice, promote the proliferation of FGSCs, improve follicular development in POF mice, and enhance ovarian function.
